Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)
Status:
Terminated
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
Treatment for 3.5-8 weeks with GH (0.05 mg/kg/day) +GLN+Diet, followed by continued
compliance to the individualized oral diet and enteral GLN, will result in reduced volume of
TPN infusion/week and/or reduced frequency of TPN infusions/week.